Ryanodex Injection, Suspension
Product Images NDC 42367-540

This is a product description of a drug named RYANODEX. It's an injectable suspension used for the treatment of malignant hyperthermia when combined with supportive measures. The drug is to be reconstituted with Sterile Water for Injection, USP before use. Each single-dose vial contains 250 mg of Dantrolene Sodium, USP. The reconstitution yields 50 mg/mL. The product should be stored at controlled room temperature between 20°Cto25°C (68°Fto 77°F) and should be protected from light. Product information can be found in the package insert. It is marketed by Eagle Pharmaceuticals, Inc. and manufactured in Taiwan.*

This is a description of a medication called NDC 42367-540-32 Single-Dose Vial. It is an injectable suspension used for the treatment of malignant hyperthermia, which is a condition that can occur during anesthesia. The vial contains 50 mg of Dantrolene Sodium USP, 125 mg of Mannitol, 25 mg of Polysorbate 80, 4 mg of Povidone K12, and sufficient amounts of Sodium Hydroxide or Hydrochloric Acid to yield a suspension with a pH of approximately 10.3 when reconstituted with 5 mL of Sterile Water for Injection USP. The reconstitution yields 50 mg/mL and should be used within 6 hours after preparation. The product should be stored at 20 °C to 25 °C for injectable suspension (68 °F to 77 °F) and protected from light. The medication is marketed by Eagle Pharmaceuticals, Inc. and is for intravenous use only.*